Analisis informasi laporan arus kas sebagai alat ukur kinerja keuangan PT. Kalbe Farma Tbk Periode 2019-2022

Andini Setia Ningrum, L. Latjandu
{"title":"Analisis informasi laporan arus kas sebagai alat ukur kinerja keuangan PT. Kalbe Farma Tbk Periode 2019-2022","authors":"Andini Setia Ningrum, L. Latjandu","doi":"10.58784/mbkk.142","DOIUrl":null,"url":null,"abstract":"This study aims to determine the company's financial performance in the 2019-2022 period with measuring instruments for cash flow ratio analysis and common size analysis. This research uses a descriptive approach. The analysis used is cash flow ratio analysis and common size analysis. The results of the study using cash flow ratio analysis showed good results because there were three ratios that met the standards, namely the Fund Flow Coverage (CAD) ratio, the Cash Coverage Against Interest (CKB) ratio and the Capital Expenditure (PM) ratio, but besides that there were three ratio values that met the standards in the Cash Coverage Against Current Debt (CKHL) ratio, namely the 2019-2021 period, and one ratio value that met the standards in the Operating Cash Flow (AKO) ratio, namely the 2020 period. Common Size analysis of the largest use of cash flow in Investment activities in the 2019 period, which amounted to 15.89% which was used for the acquisition of assets and other cash expenditures from investment activities. From these results it can be concluded that the financial performance of PT Kalbe Farma Tbk for the 2019-2022 period is good.","PeriodicalId":206242,"journal":{"name":"Manajemen Bisnis dan Keuangan Korporat","volume":"17 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Manajemen Bisnis dan Keuangan Korporat","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.58784/mbkk.142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This study aims to determine the company's financial performance in the 2019-2022 period with measuring instruments for cash flow ratio analysis and common size analysis. This research uses a descriptive approach. The analysis used is cash flow ratio analysis and common size analysis. The results of the study using cash flow ratio analysis showed good results because there were three ratios that met the standards, namely the Fund Flow Coverage (CAD) ratio, the Cash Coverage Against Interest (CKB) ratio and the Capital Expenditure (PM) ratio, but besides that there were three ratio values that met the standards in the Cash Coverage Against Current Debt (CKHL) ratio, namely the 2019-2021 period, and one ratio value that met the standards in the Operating Cash Flow (AKO) ratio, namely the 2020 period. Common Size analysis of the largest use of cash flow in Investment activities in the 2019 period, which amounted to 15.89% which was used for the acquisition of assets and other cash expenditures from investment activities. From these results it can be concluded that the financial performance of PT Kalbe Farma Tbk for the 2019-2022 period is good.
作为 PT Kalbe Farma Tbk 公司 2019-2022 年财务业绩衡量工具的现金流量表信息分析。
本研究旨在通过现金流比率分析和共同规模分析的测量工具,确定公司在 2019-2022 年期间的财务业绩。本研究采用描述性方法。使用的分析方法是现金流比率分析和共同规模分析。使用现金流比率分析的研究结果显示效果良好,因为有三个比率值达标,分别是资金流覆盖率(CAD)、现金覆盖利息比率(CKB)和资本支出比率(PM),除此之外,现金覆盖流动负债比率(CKHL)有三个比率值达标,分别是2019-2021年,经营现金流比率(AKO)有一个比率值达标,分别是2020年。共同规模分析,2019 年期间投资活动现金流使用量最大,达 15.89%,用于购置资产和投资活动的其他现金支出。从这些结果可以得出结论,PT Kalbe Farma Tbk 公司 2019-2022 年期间的财务业绩良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信